title: Interstitial lung disease associated with oxaliplatin: description of two cases.
authors.forename: C
authors.initials: C
authors.lastname: Pena Alvarez
authors.forename: H J
authors.initials: HJ
authors.lastname: Suh Oh
authors.forename: A
authors.initials: A
authors.lastname: Sáenz de Miera Rodríguez
authors.forename: F R
authors.initials: FR
authors.lastname: García Arroyo
authors.forename: M
authors.initials: M
authors.lastname: Covela Rúa
authors.forename: L
authors.initials: L
authors.lastname: Salgado Boquete
authors.forename: P M
authors.initials: PM
authors.lastname: López Clemente
authors.forename: M
authors.initials: M
authors.lastname: Constenla Figueiras
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
chemical_list: D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil